Weekly rifapentine/lsoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contactsSCHECHTER, Mauro; ZAJDENVERG, Roberto; FALCO, Gisely et al.American journal of respiratory and critical care medicine. 2006, Vol 173, Num 8, pp 922-926, issn 1073-449X, 5 p.Article

Primary Antiretroviral Drug Resistance among HIV Type 1-Infected Individuals in BrazilSPRINZ, Eduardo; NETTO, Eduardo M; LIMA, Maria Patelli J. S et al.AIDS research and human retroviruses. 2009, Vol 25, Num 9, pp 861-867, issn 0889-2229, 7 p.Article

Health-related quality of life outcomes in HIV-infected patients starting different combination regimens in a randomized multinational trial : The INITIO-QoL substudyBUCCIARDINI, Raffaella; FRAGOLA, Vincenzo; MASSELLA, Maurizio et al.AIDS research and human retroviruses. 2007, Vol 23, Num 10, pp 1215-1222, issn 0889-2229, 8 p.Article

Similar Safety and Efficacy of Once- and Twice-Daily Lopinavir/Ritonavir Tablets in Treatment-Experienced HIV-1-Infected Subjects at 48 WeeksZAJDENVERG, Roberto; PODSADECKI, Thomas J; BADAL-FAESEN, Sharlaa et al.Journal of acquired immune deficiency syndromes (1999). 2010, Vol 54, Num 2, pp 143-151, issn 1525-4135, 9 p.Article

Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trialsERON, Joseph J; YOUNG, Benjamin; KUMAR, Princy N et al.Lancet (British edition). 2010, Vol 375, Num 9712, pp 396-407, issn 0140-6736, 12 p.Article

Effects of boosted tipranavir and lopinavir on body composition, insulin sensitivity and adipocytokines in antiretroviral-naive adultsCARR, Andrew; RITZHAUPT, Armin; WEI ZHANG et al.AIDS (London). 2008, Vol 22, Num 17, pp 2313-2321, issn 0269-9370, 9 p.Article